MAP2K7 and neoplasm: Mice treated with the drug combination had significantly smaller tumours than mice treated only with MEK inhibitor or only with digitoxin in 8 of 11 melanomas (M481, M487, M405, M634, M214, M514, M715, M660; Fig. 2a).